Literature DB >> 7308191

A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus.

A W Wyke, J B Ward, M V Hayes, N A Curtis.   

Abstract

The degree of cross-linking of the peptidoglycan of Staphylococcus aureus H and mutants lacking penicillin-binding proteins 1 and 4 was studied. No major changes were observed in organisms lacking protein 1 whereas loss of protein 4 was accompanied by a marked reduction in the degree of cross-linking and the absence of a membrane-bound 'model' transpeptidase activity. A similar effect was achieved when cultures of the staphylococci were treated with the beta-lactam antibiotic cefoxitin. At low concentrations (0.05 microgram ml-1) cefoxitin shows highest affinity for protein 4 to which it appears to bind irreversibly. Treatment of the mutant lacking protein 4 with this concentration of the antibiotic did not affect the degree of cross-linkage. The possibility that the decrease in cross-linkage was a consequence of DD-carboxypeptidase activity on peptidoglycan precursors was investigated. Although both S. aureus H and the mutants possessed such activity it was insensitive to benzylpenicillin and cefoxitin and the role of this enzyme(s) in peptidoglycan biosynthesis remains unknown. We conclude that in vivo protein 4 acts as a transpeptidase involved in the secondary cross-linking of peptidoglycan and this activity is necessary to achieve the high degree of cross-linkage observed in the peptidoglycan of staphylococci.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308191     DOI: 10.1111/j.1432-1033.1981.tb05620.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  56 in total

1.  The AbcA transporter of Staphylococcus aureus affects cell autolysis.

Authors:  G Schrader-Fischer; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Fluorescent reporters for studies of cellular localization of proteins in Staphylococcus aureus.

Authors:  Pedro M Pereira; Helena Veiga; Ana M Jorge; Mariana G Pinho
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

3.  Unusual septum formation in Streptococcus pneumoniae mutants with an alteration in the D,D-carboxypeptidase penicillin-binding protein 3.

Authors:  C Schuster; B Dobrinski; R Hakenbeck
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

4.  The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.

Authors:  Dhritiman Samanta; Mohamed O Elasri
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 5.  Bacterial cell wall synthesis: new insights from localization studies.

Authors:  Dirk-Jan Scheffers; Mariana G Pinho
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

6.  In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Y Sumita; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

7.  Nanoscale cell wall deformation impacts long-range bacterial adhesion forces on surfaces.

Authors:  Yun Chen; Akshay K Harapanahalli; Henk J Busscher; Willem Norde; Henny C van der Mei
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

8.  Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus.

Authors:  H F Chambers; M J Sachdeva; C J Hackbarth
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.

Authors:  J E Finan; G L Archer; M J Pucci; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.

Authors:  H F Chambers; B J Hartman; A Tomasz
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.